Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,095) with videos related to
Page
of 110
Sort By:
Alimentary Pharmacology & Therapeutics
|
May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Juan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Journal of Hepatology
|
June 17, 2019
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Jordi Llaneras, Mar Riveiro-Barciela, Sabela Lens, et al.
Targeted Oncology
|
September 17, 2024
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)
Daniele Santini, Haoran Li, Giandomenico Roviello, et al.
Journal of Hepatology
|
August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
Maria Buti, Jeong Heo, Yasuhito Tanaka, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2024
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study
Carlo Messina, Martina Catalano, Giandomenico Roviello, et al.
Cancer Immunology, Immunotherapy : CII
|
November 14, 2025
Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study
Ray Manneh Kopp, Francesco Massari, Enrique Grande, et al.
Gut
|
June 4, 2025
Differential HCC risk among HBV indeterminate types at baseline and by phase transition
Rui Huang, Huy N Trinh, Satoshi Yasuda, et al.
The Journal of Infectious Diseases
|
May 17, 2021
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
Yao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al.
HGG Advances
|
June 30, 2024
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
Jannik Boos, Caspar I van der Made, Gayatri Ramakrishnan, et al.
Frontiers in Oncology
|
March 6, 2026
Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study
Francesco Pantano, Andrea Malgeri, Ugo De Giorgi, et al.
Page
of 110
Search research articles
Search
Showing results (991-1000 of 1,095) with videos related to
Sort By:
Page
of 110
Alimentary Pharmacology & Therapeutics
|
May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Juan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Journal of Hepatology
|
June 17, 2019
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Jordi Llaneras, Mar Riveiro-Barciela, Sabela Lens, et al.
Targeted Oncology
|
September 17, 2024
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)
Daniele Santini, Haoran Li, Giandomenico Roviello, et al.
Journal of Hepatology
|
August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
Maria Buti, Jeong Heo, Yasuhito Tanaka, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2024
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study
Carlo Messina, Martina Catalano, Giandomenico Roviello, et al.
Cancer Immunology, Immunotherapy : CII
|
November 14, 2025
Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study
Ray Manneh Kopp, Francesco Massari, Enrique Grande, et al.
Gut
|
June 4, 2025
Differential HCC risk among HBV indeterminate types at baseline and by phase transition
Rui Huang, Huy N Trinh, Satoshi Yasuda, et al.
The Journal of Infectious Diseases
|
May 17, 2021
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
Yao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al.
HGG Advances
|
June 30, 2024
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
Jannik Boos, Caspar I van der Made, Gayatri Ramakrishnan, et al.
Frontiers in Oncology
|
March 6, 2026
Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study
Francesco Pantano, Andrea Malgeri, Ugo De Giorgi, et al.
Page
of 110